
| 2019 | |
|---|---|
| Criterium: | Position: |
| Overall Score: | > 1000 |
| Total Project Funding per Partner: | > 1000 |
| Total Number of Projects: | > 1000 |
| 2012 | |
| Criterium: | Position: |
| Overall Score: | > 1000 |
| Networking Rank (Reputation): | > 1000 |
| Networking Rank (Reputation): | > 1000 |
| 2009 | |
| Criterium: | Position: |
| Overall Score: | > 1000 |
| Networking Rank (Reputation): | > 1000 |
Total number of projects: 3
As coordinator: 0
As participant: 3
Sole participant: 0
Coordinator / Participant Ratio: 0*
| Total project funding [€]: | Projects [No]: | |||||
|---|---|---|---|---|---|---|
| Year: | coordinator* | participant* | per partner | as coordinator | as participant | |
| 2019 | 0 | 1.039.600 | 23.000 | 1 | ||
| 2017 | 0 | 7.595.715 | 188.465 | 1 | ||
| 2012 | 0 | 5.989.000 | 352.294 | 1 | ||
Total number of partners: 38
Partner loyalty:
Frequent Partner: (> 2 projects): 0
Rare Partner: 38
Frequent / Rare Partner Ratio: 0
| Start date | Project | acronym | role | funding | partners |
|---|---|---|---|---|---|
| 2019-01-01 | Innovation in Tuberculosis | INNOVA4TB | participant | 1.039.600 | 16 |
| 2017-01-01 | A multicenter phase IIb study using HLA-unmatched allogeneic placenta-derived stromal cells (PLX-PAD) for the treatment of severe critical limb ischemia accompanied by mechanistic studies | PACE | participant | 7.595.715 | 8 |
| 2012-11-01 | Personalized minimization of immunosuppression after solid organ transplantation by biomarker-driven stratification of patients to improve long-term outcome and health-economic data of transplantation | BIO-DRIM | participant | 5.989.000 | 17 |